Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Genetic-epidemiological studies of apolipoprotein(a) polymorphism and its significance in nephrological diseases and type I diabetes mellitus].

Acta medica Austriaca - 1 Jan 1999

Kronenberg F, Auinger M, Dieplinger H

Abstract excerpt

Lipoprotein(a) is a highly atherogenic particle. The plasma concentrations of this lipoprotein are strongly related to a genetically determined size polymorphism of apolipoprotein(a). This article reviews some pathogenetic characteristics of the apolipoprotein(a) polymorphism besides its known effect on the lipoprotein(a) plasma concentrations. Those are the relation of the apolipoprotein(a) phenotype with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Apolipoproteins A
Share to Arteriosclerosis
Share to Austria

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Diabetic Angiopathies

Share to Diabetic Nephropathies

Share to Kidney Failure, Chronic

Share to Kidney Transplantation

Share to Renal Dialysis

Source

Identifiers

PMID: 11512190

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Genetic-epidemiological studies of apolipoprotein(a) polymorphism and its significance in nephrological diseases and type I diabetes mellitus].PMID 11512190Read ↗

[Molecular and clinical abnormalities of apolipoprotein A-I].Semantic proximity Read ↗

Apolipoprotein(a) phenotypes and serum lipoprotein(a) levels in maintenance hemodialysis patients with/without diabetes mellitus.Semantic proximity Read ↗

Elevated plasma concentrations of lipoprotein(a) in patients with end-stage renal disease are not related to the size polymorphism of apolipoprotein(a).Semantic proximity Read ↗

Genetics and metabolism of lipoprotein(a) and their clinical implications (Part 1).Semantic proximity Read ↗

[Lipoprotein (a) and its phenotype].Semantic proximity Read ↗

Genetics and cardiovascular risk: a role for apolipoprotein(a) polymorphism.Semantic proximity Read ↗

[Apolipoprotein B100 and LDL receptors: genetic and metabolic aspects].Semantic proximity Read ↗

[Lipoprotein (a)].Semantic proximity Read ↗

Lipoprotein(a) in health and disease.Semantic proximity Read ↗

Lipoprotein(a). A genetic risk factor for premature coronary heart diseaseSemantic proximity Read ↗

Serum lipoprotein(a) concentrations and apolipoprotein(a) phenotypes in hemodialysis, chronic ambulatory peritoneal dialysis and post-transplant patients.Semantic proximity Read ↗

Apolipoprotein(a) phenotypes and lipoprotein(a) concentrations in patients with renal failure.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.